Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.75 USD | -1.14% | -0.24% | -24.57% |
May. 07 | Earnings Flash (VCYT) VERACYTE Posts Q1 Revenue $96.8M, vs. Street Est of $93.4M | MT |
May. 07 | Transcript : Veracyte, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 406M | Sales 2025 * | 448M | Capitalization | 1.59B |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | 9M | EV / Sales 2024 * | 3.35 x |
Net cash position 2024 * | 226M | Net cash position 2025 * | 291M | EV / Sales 2025 * | 2.89 x |
P/E ratio 2024 * |
-402
x | P/E ratio 2025 * |
183
x | Employees | 815 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.15% |
Latest transcript on Veracyte, Inc.
1 day | -1.14% | ||
1 week | -0.24% | ||
1 month | +2.77% | ||
3 months | -13.54% | ||
6 months | -21.82% | ||
Current year | -24.57% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 21-05-31 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 21-07-18 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 08-01-31 |
Robert Epstein
CHM | Chairman | 58 | 15-01-11 |
Karin Eastham
BRD | Director/Board Member | 74 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 20.75 | -1.14% | 771,387 |
24-05-30 | 20.99 | +0.96% | 609,413 |
24-05-29 | 20.79 | -3.08% | 772,760 |
24-05-28 | 21.45 | +3.12% | 643,124 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.57% | 1.59B | |
-38.56% | 8.39B | |
+0.18% | 3.32B | |
+9.29% | 2.48B | |
-18.21% | 2.06B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M | |
-6.56% | 273M |
- Stock Market
- Equities
- VCYT Stock